跳至主要内容
临床试验/ACTRN12618001211257
ACTRN12618001211257已完成未知

Determination of clinical factors that influence insulin dose requirements during treatment of hyperglycaemia while taking prednisolone

Flinders Medical Centre0 个研究点目标入组 50 人开始时间: 2018年7月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Age greater than or equal to 18 years
  • 2. Prescribed a morning dose of oral prednisolone greater than or equal to 20 mg/day for an acute inflammatory illness.
  • 3. Hyperglycaemia in the prior 24 hours, defined as:
  • A) One point-of-care blood glucose greater than or equal to 15 mmol/L.
  • B) Two point-of-care blood glucose greater than or equal to 10 mmol/L.

排除标准

  • 1. by mouth or reduced oral intake.
  • 2. Type 1 diabetes mellitus (T1DM).
  • 3. Prescribed long-term oral prednisolone greater than or equal to 10 mg/day (or equivalent).
  • 4. Psychiatric illness or another condition precluding providing informed consent.
  • 5. Pregnancy.

研究者

相似试验